FIELD: medicine; pharmaceuticals.
SUBSTANCE: invention relates to pharmaceutical industry, namely to a cardiotonic agent in chronic heart failure. Use of a thick extract from the spring primrose (Primula veris L.) as a cardiotonic agent in chronic heart failure.
EFFECT: above-described agent is effective as a cardiotonic agent in chronic heart failure.
1 cl, 5 tbl
Title | Year | Author | Number |
---|---|---|---|
AGENT HAVING CARDIOTONIC ACTIVITY | 2012 |
|
RU2521213C1 |
HERBAL AGENT POSSESSING HEPATOPROTECTIVE ACTION | 2014 |
|
RU2554493C1 |
MEANS OF VEGETATIVE ORIGIN POSSESSING ANTIOXIDANT ACTIVITY | 2007 |
|
RU2342942C1 |
HERBAL MEDICINAL PRODUCT HAVING ENDOTHELIOPROTECTIVE ACTIVITY | 2014 |
|
RU2561064C1 |
AGENT POSSESSIVE CARDIOPROTECTIVE ACTION UNDER STRESS STIMULATION | 2013 |
|
RU2531082C1 |
AGENT POSSESSING CARDIOPROTECTIVE, ANTIPLATELET, ANTICOAGULANT AND MEMBRANE-PROTECTIVE PROPERTIES UNDER STRESS STIMULATION | 2013 |
|
RU2531080C1 |
METHOD OF CARDIOPROTECTIVE ACTIVITY ESTIMATION OF PHARMACOLOGICAL FACILITIES | 2017 |
|
RU2643104C1 |
5-POTASSIUM HYDROXINICOTINATE WITH CARDIOPROTECTIVE ACTIVITY | 2017 |
|
RU2640580C1 |
METHOD FOR TREATMENT OF ALCOHOLIC CARDIOMYOPATHY | 2017 |
|
RU2642298C1 |
2-PROPOXY METHYLCYCLOHEXANE CARBOXYLATE OF LITHIUM POSSESSING CARDIOTONIC ACTION | 1992 |
|
RU2054413C1 |
Authors
Dates
2018-05-22—Published
2017-02-10—Filed